Your browser is no longer supported. Please, upgrade your browser.
Settings
NVTA Invitae Corporation daily Stock Chart
NVTA [NYSE]
Invitae Corporation
Index- P/E- EPS (ttm)-2.55 Insider Own0.20% Shs Outstand51.58M Perf Week-1.04%
Market Cap441.01M Forward P/E- EPS next Y-1.60 Insider Trans-2.93% Shs Float47.86M Perf Month3.64%
Income-107.70M PEG- EPS next Q-0.55 Inst Own65.80% Short Float7.18% Perf Quarter-4.15%
Sales52.10M P/S8.46 EPS this Y5.00% Inst Trans23.86% Short Ratio10.61 Perf Half Y-9.81%
Book/sh2.60 P/B3.29 EPS next Y34.40% ROA-67.80% Target Price13.67 Perf Year18.92%
Cash/sh1.49 P/C5.73 EPS next 5Y8.00% ROE-115.20% 52W Range7.03 - 11.88 Perf YTD7.68%
Dividend- P/FCF- EPS past 5Y- ROI-88.80% 52W High-28.03% Beta-
Dividend %- Quick Ratio2.60 Sales past 5Y- Gross Margin20.70% 52W Low21.62% ATR0.36
Employees509 Current Ratio2.60 Sales Q/Q187.30% Oper. Margin- RSI (14)47.18 Volatility3.84% 3.58%
OptionableYes Debt/Eq0.35 EPS Q/Q26.50% Profit Margin- Rel Volume1.17 Prev Close8.55
ShortableYes LT Debt/Eq0.33 EarningsNov 06 AMC Payout- Avg Volume324.00K Price8.55
Recom2.00 SMA200.43% SMA50-3.58% SMA200-10.57% Volume0 Change0.00%
Apr-03-17Reiterated The Benchmark Company Buy $11 → $16
Feb-14-17Upgrade The Benchmark Company Hold → Buy $8.50 → $11
Nov-10-16Resumed Leerink Partners Outperform
Jun-30-16Initiated The Benchmark Company Hold $8.50
Jan-28-16Downgrade Leerink Partners Outperform → Mkt Perform
Aug-14-15Initiated William Blair Mkt Perform
May-14-15Upgrade Leerink Partners Mkt Perform → Outperform
Dec-11-17 02:04PM  ETFs with exposure to Invitae Corp. : December 11, 2017 Capital Cube
Dec-05-17 07:30AM  Multigene Genetic Testing Improves Identification and Management of Hereditary Cancer Risk for Breast Cancer Patients and Their Families PR Newswire
Dec-04-17 08:32AM  3 Great Stocks Under $10 Motley Fool
Dec-01-17 10:43AM  ETFs with exposure to Invitae Corp. : December 1, 2017 Capital Cube
Nov-30-17 09:27AM  Invitae Corp. :NVTA-US: Earnings Analysis: Q3, 2017 By the Numbers : November 30, 2017 Capital Cube
08:30AM  Edited Transcript of NVTA earnings conference call or presentation 6-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
Nov-15-17 07:30AM  Invitae Completes Acquisition of CombiMatrix, Becoming a Leader in Family and Reproductive Health Genetic Information Services PR Newswire
Nov-13-17 11:17AM  Will Invitae Ever Turn a Profit? Motley Fool
Nov-10-17 04:15PM  CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation GlobeNewswire
Nov-08-17 04:38PM  Invitae Corporation Issues Reminder Regarding Exchange Offer for CombiMatrix Corporation Series F Warrants PR Newswire
Nov-07-17 04:53PM  Here's Why Invitae Rose as Much as 13.8% Today Motley Fool +12.41%
Nov-06-17 04:42PM  Invitae reports 3Q loss Associated Press
04:01PM  Invitae Reports Double-Digit Sequential Volume and Revenue Growth in Third Quarter 2017 PR Newswire
08:30AM  Invitae Corp to Host Earnings Call ACCESSWIRE
Oct-30-17 07:30AM  Invitae Presents Validation of a Novel NGS-based Preimplantation Genetic Screening Technology to Identify the Most Frequent Chromosomal Causes of Miscarriage PR Newswire
Oct-26-17 11:08AM  Invitae Corp. Value Analysis (NYSE:NVTA) : October 26, 2017 Capital Cube
06:00AM  Safeguard Scientifics Announces Third Quarter 2017 Financial Results PR Newswire
Oct-25-17 08:14AM  Invitae Corp. breached its 50 day moving average in a Bearish Manner : NVTA-US : October 25, 2017 Capital Cube
Oct-24-17 07:30AM  Invitae to announce third quarter 2017 Financial Results and Host Conference Call on November 6, 2017 PR Newswire
Oct-23-17 10:52AM  ETFs with exposure to Invitae Corp. : October 23, 2017 Capital Cube
Oct-17-17 07:30AM  Invitae data shows increased diagnosis rates with custom NGS technique allowing simultaneous genetic sequencing and copy number variant detection PR Newswire
Oct-12-17 10:46AM  ETFs with exposure to Invitae Corp. : October 12, 2017 Capital Cube
07:47AM  3 Signs Myriad Genetics' High-Growth Days Are Over Motley Fool
Oct-06-17 07:30AM  Invitae Commences Exchange Offer for CombiMatrix Series F Warrants PR Newswire
Oct-05-17 07:30AM  Invitae's new framework for classifying genetic variants aims to improve consistency of genetic test results industry-wide PR Newswire
Oct-04-17 07:45AM  3 Top Small-Cap Stocks to Buy in October Motley Fool
Oct-03-17 08:12AM  Invitae Corp. breached its 50 day moving average in a Bullish Manner : NVTA-US : October 3, 2017 Capital Cube
02:00AM  Atlas Genetics Appoints Life Sciences Veteran, Jeffrey Luber, as Chief Executive Officer; Founding CEO Dr John Clarkson Steps Up to Executive Chairman PR Newswire
Sep-25-17 10:42AM  ETFs with exposure to Invitae Corp. : September 25, 2017 Capital Cube
Sep-14-17 06:47PM  ETFs with exposure to Invitae Corp. : September 14, 2017 Capital Cube
Sep-13-17 11:25AM  Invitae Corp. :NVTA-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017 Capital Cube
07:35AM  Invitae highlighting new research, expanded suite of services at National Society of Genetic Counselors (NSGC) 36th Annual Conference PR Newswire
07:30AM  Invitae to Present at the Cantor Fitzgerald Global Healthcare Conference PR Newswire
Sep-08-17 11:06AM  Invitae Corp. breached its 50 day moving average in a Bearish Manner : NVTA-US : September 8, 2017 Capital Cube
Aug-29-17 07:30AM  Invitae to Participate in the Morgan Stanley 15th Annual Global Healthcare Conference PR Newswire
Aug-16-17 02:07PM  3 Stocks Set to Pop Motley Fool
Aug-15-17 06:21PM  Invitae Corp. Value Analysis (NYSE:NVTA) : August 15, 2017 Capital Cube
09:06AM  Invitae Corp. breached its 50 day moving average in a Bullish Manner : NVTA-US : August 15, 2017 Capital Cube
Aug-13-17 12:35AM  Edited Transcript of NVTA earnings conference call or presentation 7-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-08-17 12:00AM  Invitae reports 2Q loss Associated Press -8.79%
Aug-07-17 04:05PM  Invitae Reports Second Quarter 2017 Results PR Newswire
Aug-03-17 08:57PM  ETFs with exposure to Invitae Corp. : August 4, 2017 Capital Cube
Aug-01-17 05:39PM  CombiMatrix shares jump on buyout news Investing.com +7.65%
09:12AM  Invitae Corp. breached its 50 day moving average in a Bearish Manner : NVTA-US : August 1, 2017 Capital Cube
Jul-31-17 05:15PM  Safeguard Scientifics Partner Company Good Start Genetics To Be Acquired By Invitae Corporation PR Newswire
04:59PM  CombiMatrix Enters Into Merger Agreement with Invitae Corporation to be Acquired for $33 Million in Invitae Common Stock GlobeNewswire
04:57PM  Invitae Acquiring Good Start Genetics and CombiMatrix, Adding Comprehensive Reproductive Health Capabilities to Serve Every Stage of Life PR Newswire
04:54PM  Invitae Announces $73.5 Million Private Placement Offering to Fuel Strategic Growth Opportunities and Reports Preliminary Second Quarter Financial Results PR Newswire
Jul-29-17 02:06PM  3 Companies Whose Sales Could Double in 2017 Motley Fool
Jul-24-17 05:41PM  ETFs with exposure to Invitae Corp. : July 24, 2017 Capital Cube
07:30AM  Invitae to Announce Second Quarter 2017 Financial Results and Host Conference Call on August 7, 2017 PR Newswire
Jul-14-17 03:57PM  ETFs with exposure to Invitae Corp. : July 14, 2017 Capital Cube
Jul-12-17 08:31AM  Invitae Corp. breached its 50 day moving average in a Bullish Manner : NVTA-US : July 12, 2017 Capital Cube
Jun-29-17 03:13PM  ETFs with exposure to Invitae Corp. : June 29, 2017 Capital Cube
Jun-28-17 09:00AM  Invitae Corp. breached its 50 day moving average in a Bearish Manner : NVTA-US : June 28, 2017 Capital Cube
Jun-14-17 08:15AM  Featured Company News - Invitae Acquires Ommdom; Gets CancerGene Connect Under its Portfolio Accesswire
Jun-12-17 07:30AM  Invitae Acquires CancerGene Connect, Award-Winning Risk Assessment and Family History Analysis Platform PR Newswire
Jun-05-17 02:35PM  ETFs with exposure to Invitae Corp. : June 5, 2017 Capital Cube
08:17AM  ASCO Data Shows Prostate Cancer Patients with Genetic Risk Factors Missed Under Current Testing Guidelines PR Newswire
Jun-02-17 10:18AM  Invitae Corp. :NVTA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 Capital Cube
Jun-01-17 09:08AM  Invitae to present at the Goldman Sachs 38th Annual Global Healthcare Conference PR Newswire
May-26-17 04:56PM  How a cancer test maker started by former Twitter, Google execs hopes to change the world American City Business Journals
May-25-17 07:30AM  Invitae Broadens Management Team to Scale Expanding Business and Meet Rising Demand PR Newswire
May-12-17 07:30AM  Invitae to Present at the UBS Global Healthcare Conference PR Newswire
May-10-17 08:51AM  Invitae Corp. breached its 50 day moving average in a Bearish Manner : NVTA-US : May 10, 2017 Capital Cube
May-08-17 04:17PM  Invitae reports 1Q loss Associated Press
04:01PM  Invitae Exceeds 26,000 Samples Accessioned, Reports Revenue of $10.3 Million and Net Loss of $0.64 Per Share in First Quarter 2017 PR Newswire
Apr-28-17 04:08PM  ETFs with exposure to Invitae Corp. : April 28, 2017 Capital Cube
07:30AM  New research suggests current genetic testing guidelines may miss breast cancer patients who could benefit from testing PR Newswire
Apr-27-17 07:30AM  Invitae to Present at the Bank of America Merrill Lynch 2017 Health Care Conference PR Newswire
Apr-24-17 03:40PM  Invitae Corp. Value Analysis (NYSE:NVTA) : April 24, 2017 Capital Cube
07:30AM  Invitae to Announce First Quarter 2017 Financial Results and Host Conference Call on May 8, 2017 PR Newswire
Apr-21-17 08:45AM  Invitae Corp. breached its 50 day moving average in a Bullish Manner : NVTA-US : April 21, 2017 Capital Cube
Apr-20-17 07:30AM  Invitae announces expansion of its genetic test menu with addition of new tests and expanded panels for inherited metabolic and immune system disorders, including panels to confirm diagnoses suggested by newborn screening PR Newswire
Apr-06-17 10:41AM  A DNA-testing company is offering patients a chance to help find a cure for their conditions Business Insider
09:00AM  Invitae expands its Genome Network with the launch of the Invitae Patient Insights Network (PIN), enabling participants to share health information and contribute to research PR Newswire
Apr-03-17 07:30AM  Invitae announces new partnership with Alnylam Pharmaceuticals to provide TTR gene testing for patients suspected of having hereditary ATTR amyloidosis PR Newswire
Mar-30-17 03:05PM  3 Top Small-Cap Stocks to Buy Heading into April Motley Fool
07:30AM  Invitae announces introduction of exome testing PR Newswire
Mar-29-17 01:48PM  Shark Bites: Traders Could Trip on This Market Bounce TheStreet.com +5.51%
Mar-23-17 01:04PM  INVITAE CORP Financials
07:30AM  Invitae Expands Test Menu for Proactive Genetic Testing in Healthy Adults PR Newswire
Mar-22-17 07:30AM  Invitae announces expansion of its genetic testing offering to include unique test for Spinal Muscular Atrophy (SMA) during the 2017 ACMG Annual Clinical Genetics Meeting PR Newswire
Mar-19-17 11:45AM  3 Companies Whose Sales Could Double in 2017 Motley Fool
Mar-16-17 04:21PM  INVITAE CORP Files SEC form 10-K, Annual Report
Mar-14-17 07:30AM  Invitae to present seventeen posters and presentations at the 2017 American College of Medical Genetics Annual Clinical Genetics Meeting PR Newswire
Mar-07-17 01:23PM  The Best Bet in the Growing Genetic Testing Market: Genetic Health vs. Invitae Motley Fool
Feb-21-17 11:07AM  Invitae to present at the Cowen and Company 37th Annual Health Care Conference PR Newswire +7.23%
Feb-17-17 07:30AM  New research suggests broader genetic testing of prostate cancer patients may be warranted to identify risk of an inherited mutation that might inform treatment PR Newswire
Feb-16-17 01:07PM  Invitae Corp. :NVTA-US: Earnings Analysis: 2016 By the Numbers : February 16, 2017 -5.13%
Feb-15-17 12:01PM  Invitae Corp. :NVTA-US: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017
Feb-14-17 08:41AM  Invitae upgraded by The Benchmark Company +7.21%
Feb-13-17 04:42PM  INVITAE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:32PM  Invitae reports 4Q loss
04:01PM  Invitae reports revenue of $9.2 million in fourth quarter 2016 and projects strong volume and revenue growth in 2017 PR Newswire
01:00PM  5 Earnings Short-Squeeze Plays
07:07AM  Q4 2016 Invitae Corp Earnings Release - Time Not Supplied
Feb-09-17 05:02PM  INVITAE CORP Files SEC form 8-K, Change in Directors or Principal Officers
Jan-31-17 09:14AM  Growth Investing 2017: 3 Stocks to Put on Your Radar at Motley Fool
Jan-30-17 07:30AM  Invitae to announce fourth quarter and year-end 2016 financial results and 2017 guidance and will host conference call on February 13, 2017 PR Newswire
Invitae Corporation, a genetic information company, focuses on bringing comprehensive genetic information into mainstream medical practice to enhance the quality of healthcare in the United States, Canada, Israel, and internationally. The company processes DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for clinicians and their patients using an integrated portfolio of laboratory processes, software tools, and informatics capabilities. It provides a diagnostic service comprising hundreds of genes for various genetic disorders associated with oncology, cardiology, neurology, pediatrics, and other rare disease areas. The company also offers solutions that enable sharing of genetic information consisting of Invitae Family History Tool, an online portal and mobile application that communicates sensitive patient data. In addition, it provides gene sequencing and deletion/duplication analysis; and free re-requisition of additional data within the same indication when ordered, as well as invests in informatics solutions and infrastructure that enable sharing of genetic information to enhance healthcare and clinical outcomes. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dumond PattyVP Fin. & Principal Acct. Off.Oct 10Sale10.006156,15052,168Oct 11 05:51 PM
Dumond PattyVP Fin. & Principal Acct. Off.Oct 09Sale10.001,88218,82052,783Oct 11 05:51 PM
Stueland KatherineChief Commercial OfficerSep 12Sale9.406125,75358,570Sep 14 02:32 PM
Brida ThomasGeneral CounselFeb 16Sale9.697667,42024,720Feb 17 05:01 PM
Nussbaum Robert LChief Medical OfficerFeb 15Sale9.531,68616,06861,137Feb 15 08:22 PM
Stueland KatherineChief Commercial OfficerFeb 15Sale9.509118,65559,182Feb 15 08:23 PM
Brida ThomasGeneral CounselFeb 15Sale9.547947,57325,486Feb 15 08:20 PM
Dumond PattyVP Fin. & Principal Acct. Off.Feb 15Sale9.551,26412,06854,665Feb 15 08:21 PM
BENDEKGEY E LEEChief Financial OfficerFeb 15Sale9.592,09820,12058,784Feb 15 08:19 PM